State of New Jersey Common Pension Fund D’s Akero Therapeutics AKRO Stock Holding History

State of New Jersey Common Pension Fund D’s Portfolio AKRO Stock Details AKRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-44,048	Closed	-$2.09M	–	1476
2025 Q3	$2.09M	Buy	44,048 +5,587	+15%	+$271K	0.01%	1220
2025 Q2	$2.05M	Sell	38,461 -541	-1%	-$24.6K	0.01%	1010
2025 Q1	$1.58M	Buy	+39,002	New	+$1.65M	0.01%	1401
2023 Q4	–	Sell	-50,259	Closed	-$2.54M	–	1550
2023 Q3	$2.54M	Sell	50,259 -3,483	-6%	-$162K	0.01%	1000
2023 Q2	$2.51M	Buy	+53,742	New	+$2.46M	0.01%	1313

Other funds holding AKRO

DekaBank Deutsche Girozentrale Frankfurt, Germany $59.2B AUM 26.02% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

State of New Jersey Common Pension Fund D's AKRO Position: Q4 2025 in Review

State of New Jersey Common Pension Fund D sold out of Akero Therapeutics (AKRO) in Q4 2025, closing a stake of 44,048 shares — an estimated $2.09M sold.

State of New Jersey Common Pension Fund D first reported a position in AKRO in Q2 2023 and held it in 5 quarters. The position peaked at $2.54M in Q3 2023. 2 funds tracked by Wall St. Rank hold AKRO as of Q4 2025.

State of New Jersey Common Pension Fund D reported no remaining Akero Therapeutics position as of Q4 2025 after selling out during the quarter.
State of New Jersey Common Pension Fund D sold 44,048 Akero Therapeutics shares in Q4 2025, an estimated $2.09M.
State of New Jersey Common Pension Fund D first reported a position in Akero Therapeutics in Q2 2023 and held it in 5 quarters.
State of New Jersey Common Pension Fund D's Akero Therapeutics position peaked at $2.54M in Q3 2023.
2 funds tracked by Wall St. Rank held Akero Therapeutics as of Q4 2025.

Based on State of New Jersey Common Pension Fund D's 13F filing for Q4 2025, filed 30 Jan 2026.